The beneficial use of berberine to lower insulin resistance and hypoglycemia in pregnant women with GDM is advocated by the existing proof about the way berberine lowers the levels and determines a higher degree of methylation of the hypoxia-inducible factor-3α gene (HIF3A), the gene related to insulin sensitivity in adipose tissue [71]. The gene discussed is HIF3A; the disease is gestational diabetes.